Elevation of serum cholesterol and triglycerides as a complication of amiodarone therapy.
作者信息
Cantor J
出版信息
J R Coll Gen Pract. 1989 Jun;39(323):258.
Abstract
摘要
相似文献
1
Elevation of serum cholesterol and triglycerides as a complication of amiodarone therapy.作为胺碘酮治疗并发症的血清胆固醇和甘油三酯升高。
J R Coll Gen Pract. 1989 Jun;39(323):258.
2
A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.一项比较索他洛尔、胺碘酮和地高辛转复新发房颤的疗效和安全性的前瞻性随机对照试验。
Ann Emerg Med. 2000 Jul;36(1):1-9. doi: 10.1067/mem.2000.107655.
3
[Amiodarone in the pharmacologic conversion of arrhythmia caused by atrial fibrillation. Intravenous therapy versus treatment per os].
Minerva Cardioangiol. 1987 Oct;35(10):539-44.
4
[Amiodarone treatment against atrial fibrillation caused thyrotoxicosis].胺碘酮治疗房颤所致甲状腺毒症
Lakartidningen. 2005;102(16):1231-3.
5
Serum creatinine increase associated with amiodarone therapy.胺碘酮治疗相关的血清肌酐升高。
N Y State J Med. 1987 Jun;87(6):358-9.
6
[Amiodarone and verapamil/quinidine in treatment of patients with chronic atrial fibrillation].[胺碘酮与维拉帕米/奎尼丁治疗慢性心房颤动患者]
Z Kardiol. 1994;83 Suppl 5:101-8.
7
Our experience with amiodarone administration to patients with paroxysmal atrial fibrillation.
Acta Univ Palacki Olomuc Fac Med. 1988;120:283-8.
8
Amiodarone for the treatment of persistent atrial fibrillation.
J Fam Pract. 1999 May;48(5):334-5.
9
10
引用本文的文献
1
Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.胺碘酮。其药理特性概述及其在心律失常治疗中的应用综述。
Drugs. 1992 Jan;43(1):69-110. doi: 10.2165/00003495-199243010-00007.
本文引用的文献
1
Can amiodarone induce hyperglycaemia and hypertriglyceridaemia?胺碘酮会诱发高血糖和高甘油三酯血症吗？
Br Med J (Clin Res Ed). 1984 Jan 28;288(6413):285. doi: 10.1136/bmj.288.6413.285.
2
Thyroid dysfunction during chronic amiodarone therapy.
J Am Coll Cardiol. 1987 Jan;9(1):175-83. doi: 10.1016/s0735-1097(87)80098-0.
Zotero 插件